NSIM
PMN icon

North Star Investment Management’s ProMIS Neurosciences PMN Stock Holding History

North Star Investment Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$212 – 1607
2025
Q3 		$212 Buy
+20
New +$277 ﹤0.01% 1292

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

North Star Investment Management's PMN Position: Q4 2025 in Review

North Star Investment Management sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 20 shares — an estimated $212 sold.

North Star Investment Management first reported a position in PMN in Q3 2025 and held it in 1 quarter. The position peaked at $212 in Q3 2025. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • North Star Investment Management reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • North Star Investment Management sold 20 ProMIS Neurosciences shares in Q4 2025, an estimated $212.
  • North Star Investment Management first reported a position in ProMIS Neurosciences in Q3 2025 and held it in 1 quarter.
  • North Star Investment Management's ProMIS Neurosciences position peaked at $212 in Q3 2025.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on North Star Investment Management's 13F filing for Q4 2025, filed 30 Jan 2026.